- US-listed companies
- Profound Medical Corp.
- Income statement
Profound Medical Corp.PROF
Market cap
$220.29M
P/E ratio
| 2019/12 | 2020/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | - | 7 | 7 | 7 | 11 |
| Revenue growth (%) | - | - | |||
| Cost of revenue | - | - | - | - | 4 |
| Gross profit | - | 3 | 3 | 4 | 7 |
| Gross margin (%) | |||||
| Research & development | - | 10 | 15 | 14 | 17 |
| Selling, general & administrative | - | - | - | - | 23 |
| Operating margin (%) | |||||
| Operating income | - | -19 | -32 | -29 | -33 |
| Operating expenses | - | - | - | - | 40 |
| Income before tax | - | -22 | -28 | -29 | -28 |
| Pretax margin (%) | -361.8 | -295.4 | -424.8 | -398.6 | -260.5 |
| Provision for income taxes | - | - | - | - | -0 |
| Effective tax rate (%) | - | - | - | - | |
| Net income | - | -22 | -29 | -29 | -28 |
| Net income margin (%) | |||||
| Earnings per share | - | - | - | - | 1.12 |
| Diluted EPS | - | - | - | - | 1.12 |